The new investment in the Holly Springs facility is on top of the initial commitment in May 2025, and groundbreaking in August 2025.
The discovery fundamentally changes the understanding of a structure in the avian eye that has been misinterpreted for centuries.
The so-called magneto-sensitive fluorescent proteins or MFPs, overcome key limitations of previous biological candidates for quantum sensors.
Danish researchers have created new cell lines that need a less tailored feeding schedule and produce fewer waste products.
Manufacturing differences between ranibizumab and aflibercept biosimilars might shape pricing, uptake, and patient access globally.
D printing is a good option for bioreactor production. The flexibility of the approach outweighs concerns about higher costs.
Lab-scale production of medicarpin in yeast heralds another manufacturing option for this natural anti-tumor agent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback